SCHEDULE: Core Scientific Inc. Major Shareholder Sells Significant Stake

Sentiment:

Schedule 13D Amendment


Reporting persons associated with Core Scientific, Inc. have disclosed substantial sales of the company's common stock over the past 60 days, reducing their beneficial ownership.

Summary

  • Reporting persons, including Situational Awareness LP, SAF AI GP LP, Situational Awareness LLC, Situational Awareness Partners LP, Leopold Aschenbrenner, and Carl Shulman, have disclosed transactions involving Core Scientific, Inc. common stock.
  • During the 60 days preceding July 15, 2026, there were purchases and sales totaling 400,000 shares.
  • Specifically, on July 14, 2026, 134,011 shares were sold at $22.4083 per share, and on July 15, 2026, 265,989 shares were sold at $22.1836 per share.
  • Further significant sales occurred on August 3, 2026, involving 5,759,539 shares sold through block trades at prices of $19.6896 and $19.4807 per share.
  • As of August 4, 2026, the reporting persons collectively beneficially owned 14,089,395 shares, representing 4.4% of the outstanding common stock.
  • This is a reduction from their beneficial ownership as of July 15, 2026, when they may have been deemed to beneficially own 25,608,473 shares, representing 8.1% of the outstanding common stock.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significant share sales by reporting persons, indicating a potential lack of confidence or a strategic divestment.

Negatives

  • Significant sales of Core Scientific, Inc. common stock by major reporting persons have occurred.
  • On July 14, 2026, 134,011 shares were sold at $22.4083 per share.
  • On July 15, 2026, 265,989 shares were sold at $22.1836 per share.
  • On August 3, 2026, a substantial block of 5,759,539 shares was sold at $19.6896 and $19.4807 per share.
  • The beneficial ownership of the reporting persons has decreased from 8.1% (25,608,473 shares) as of July 15, 2026, to 4.4% (14,089,395 shares) as of August 4, 2026.

Risks

  • The substantial sales by reporting persons could indicate a lack of confidence in the company's future performance or a strategic decision to reduce exposure.
  • Continued selling pressure from significant holders could negatively impact the stock price.

Future Outlook

No specific forward-looking statements or guidance are provided in this filing; it solely details past transactions.

Industry Context

StockSavvy.ai notes that significant share sales by major holders in the cryptocurrency mining sector, like Core Scientific, can be influenced by market volatility, regulatory changes, or the holders' own strategic capital allocation decisions.

Stakeholder Impact

  • Shareholders may experience negative price pressure due to the significant volume of shares sold by reporting persons.
  • Potential investors may view the substantial divestment by reporting persons as a negative signal, potentially impacting future investment decisions.

Key Dates

DateDescription
2026-03-31End of quarterly period for which outstanding shares were reported in the May 6, 2026 10-Q.
2026-05-06Date of filing of Core Scientific, Inc.'s Quarterly Report on Form 10-Q for the period ended March 31, 2026.
2026-06-30End of quarterly period for which outstanding shares were reported in the July 28, 2026 10-Q.
2026-07-15Date as of which reporting persons' beneficial ownership was 8.1% (25,608,473 shares).
2026-07-23Date as of which outstanding shares were reported in the July 28, 2026 10-Q.
2026-07-28Date of filing of Core Scientific, Inc.'s Quarterly Report on Form 10-Q for the period ended June 30, 2026.
2026-08-03Date of block trades involving sale of 5,759,539 shares.
2026-08-04Date as of which reporting persons' beneficial ownership was 4.4% (14,089,395 shares).

Recommendation

hold

The filing details significant share sales by reporting persons, which is a negative indicator. However, without further information on the company's financial health or strategic direction, a 'hold' recommendation is prudent, allowing for further observation of market reaction and company performance.

Keywords

Core Scientific, Schedule 13D, Beneficial Ownership, Stock Transactions, Block Trades, Share Sales, Situational Awareness LP, Leopold Aschenbrenner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.